Novartis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies.
CEOVasant Narasimhan
CEOVasant Narasimhan
Employees75,267
Employees75,267
HeadquartersBasel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded1996
Founded1996
Employees75,267
Employees75,267
NVS Key Statistics
Market cap309.35B
Market cap309.35B
Price-Earnings ratio22.03
Price-Earnings ratio22.03
Dividend yield2.10%
Dividend yield2.10%
Average volume1.66M
Average volume1.66M
High today$151.74
High today$151.74
Low today$148.40
Low today$148.40
Open price$150.67
Open price$150.67
Volume1.73M
Volume1.73M
52 Week high$170.46
52 Week high$170.46
52 Week low$121.57
52 Week low$121.57
NVS News
Reuters 2d
Novartis ends mid-stage Fabhalta trial targeting serious kidney condition - Reuters...
TipRanks 2d
Novartis terminates mid-stage trial of lupus nephritis treatment, Endpoints saysNovartis (NVS) has scrapped a mid-stage trial of Fabhalta in lupus nephritis, citing “strategic considerations,” Endpoints News’ Lei Lei Wu reports, citing a fe...
Analyst ratings
67%
of 9 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.